|
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 17.00 | ACUITE BB+ | Downgraded | Issuer not co-operating* | - |
Bank Loan Ratings | 7.00 | - | ACUITE A4+ | Downgraded | Issuer not co-operating* |
Total Outstanding | 24.00 | - | - |
Total Withdrawn | 0.00 | - | - |
* The issuer did not co-operate; based on best available information. |
Rating Rationale |
Acuité has downgraded its long-term rating to ‘ACUITE BB+’ (read as ACUITE double B plus) from 'ACUITE BBB-' (read as ACUITE Triple B minus) and its short-term rating to 'ACUITE A4+' (read as ACUITE A four plus) from 'ACUITE A3+' (read as ACUITE A three plus) on the Rs. 24 crore bank facilities of Sneha Medicare Private Limited. |
About the Company |
Sneha Medicare Private Limited, incorporated in 2002, is engaged in the business of trading of active pharmaceutical intermediates (APIs), pharmaceutical formulations. Sneha Medicare Private Limited has registered office in Mumbai. The current Directors of the firm are Mr. Kirti Shah and Mr. Pratik Shah. |
Unsupported Rating |
Not Applicable |
Non-cooperation by the issuer/borrower |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is therefore being flagged as “Issuer not cooperating”, in line with prevailing SEBI regulations and Acuité’s policies |
Limitation regarding information availability |
The rating is based on information available from sources other than the issuer/borrower (in the absence of information provided by the issuer/borrower). Acuité endeavoured to gather information about the entity/industry from the public domain. Therefore, Acuité cautions lenders and investors regarding the use of such information, on which the indicative credit rating is based. |
Rating Sensitivities |
'No information provided by the issuer / available for Acuite to comment upon' |
Liquidity Position |
'No information provided by the issuer / available for Acuite to comment upon' |
Outlook |
Not Applicable |
Other Factors affecting Rating |
None |
Particulars | Unit | FY 23 (Actual) | FY 22 (Actual) |
Operating Income | Rs. Cr. | 376.54 | 329.94 |
PAT | Rs. Cr. | 2.96 | 7.03 |
PAT Margin | (%) | 0.79 | 2.13 |
Total Debt/Tangible Net Worth | Times | 1.44 | 0.85 |
PBDIT/Interest | Times | 3.57 | 8.76 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Trading Entitie: https://www.acuite.in/view-rating-criteria-61.htm |
Note on complexity levels of the rated instrument |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
* The issuer did not co-operate; based on best available information. |
|
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |